Star Health & Allied Insurance Company Ltd Q3 FY26 Results & Concall Highlights: Revenue, Margins & Order Book
Published 5 Aug 2026 | Insurance | Market Cap: ₹34.6K Cr
Star Health expects continued growth driven by value-driven growth and disciplined underwriting. The company experienced strong top-line growth and improved operating results in Q3 and 9M FY2026, driven by reduction in losses and expense ratio.
From Star Health & Allied Insurance Company Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.
Price
₹578
Market Cap
₹34.6K Cr
P/E Ratio
41.0
How does Star Health & Allied Insurance Company Ltd rank in Insurance?
Compare Star Health & Allied Insurance Company Ltd against every Insurance company this quarter on revenue, margins and earnings-call signals.
Star Health & Allied Insurance Company Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹4.6K Cr, net profit ₹111 Cr.
Full financials →📊 Revenue & Sales Performance
- →Star Health expects continued growth driven by value-driven growth and disciplined underwriting.
- →Fresh business growth has been strong, with 35% year-on-year growth in fresh business premiums in agency channels for 9M FY2026, and over 66% growth in Q3 FY2026 alone.
- →Renewal premium growth is around 16-17%, indicating stable recurring revenue.
- →The company is focusing on preferred geographies, demographics, products, and channels that meet ROE thresholds, with preferred segments growing 1.3x the company average.
- →Long-term policies are increasing, contributing about 23% fresh business and 51% of Gross Written Premium (GWP), supporting business stability and capital efficiency.
- →Digital initiatives have accelerated, with 94% new policies originating digitally and 76% premium collected digitally, enhancing future volume growth.
- →Growth is expected to be profitable and sustainable with ongoing pricing calibration and focus on customer retention.
📈 Profitability & Margins
- →The company experienced strong top-line growth and improved operating results in Q3 and 9M FY2026, driven by reduction in losses and expense ratio.
- →Focus remains on delivering value-driven growth with disciplined underwriting, strong fraud analytics, and deepening hospital and distributor partnerships.
- →Long-term policies increased, contributing to stronger profitability and capital efficiency.
- →Investment income yield was 9.6% for 9M FY2026, supported by 18.7% exposure in high-yield assets; equity returns expected around 10-11% correlated with nominal GDP growth.
- →Management aims to maintain combined ratio below 100% for sustainable profitability and mid-teens ROE.
- →Fresh business growth outpaced renewal growth, with robust 35-45% fresh premium increases, indicating future NEP growth acceleration.
- →Commission costs stable due to deferred acquisition cost accounting under IFRS.
- →Emphasis on consistent execution to maintain growth and profitability momentum going forward.
🏗️ Capital Expenditure Plans
💰 Fundraising & Capital Structure
- →There is no explicit mention of any current or planned future fundraising through debt or equity in the provided transcript.
- →The company discusses capital management mainly in terms of solvency and internal risk appetite for equity exposure, capped at 15%.
- →They are focused on sustainable growth, asset quality, and maintaining capital adequacy without indicating plans for new capital raises.
- →Regulatory caps and internal models influence equity and alternative investment allocations, but no fundraising plans are indicated.
📋 Order Book & Pipeline
Key Metrics
Frequently Asked Questions
What were Star Health & Allied Insurance Company Ltd Q3 FY26 results?
Star Health expects continued growth driven by value-driven growth and disciplined underwriting. The company experienced strong top-line growth and improved operating results in Q3 and 9M FY2026, driven by reduction in losses and expense ratio.
What is Star Health & Allied Insurance Company Ltd share price analysis?
Star Health & Allied Insurance Company Ltd currently shows a neutral. The stock trades at a P/E of 41.0 with a market cap of ₹34,614 Cr. Investors should review the full earnings analysis for detailed insights.
Is Star Health & Allied Insurance Company Ltd planning capital expenditure?
The transcript does not specifically mention any current or future capex, capital investment, or strategic investment plans by Star Health and Allied Insurance Company Limited.
Keep Star Health & Allied Insurance Company Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.